论文信息 - P76.62 RAMOSE: An Open-Label Randomized Phase II Study of Osimertinib with or without Ramucirumab in TKI-Naïve EGFR-Mutant Metastatic NSCLC - 字舞流文

P76.62 RAMOSE: An Open-Label Randomized Phase II Study of Osimertinib with or without Ramucirumab in TKI-Naïve EGFR-Mutant Metastatic NSCLC

N. Hanna | G. Otterson | R. Hall | X. Le | J. Gray | C. Baik | J. Patel | R. Sanborn | A. Saltos | C. Shu | M. Fidler | E. Shum | C. Kim | J. Heymach | Kwok-kin Wong